In this Demystifying Medicine video from McMaster University, learn more about idiopathic pulmonary fibrosis (IPF), a scleroderma-related condition that currently has no known cause. Back in February, researchers presented a study investigating the therapeutic effect of the monoclonal antibody CM-101 in animal models of systemic sclerosis (SSc) and…
Gallery
Social Clips
Scleroderma and the GI Tract
In this video by the Scleroderma Foundation, Greater Chicago Chapter, watch Michael Brown, MD, Professor of Medicine, Rush University Medical Center, talk about scleroderma and the gastrointestinal tract (GI). Read the latest scleroderma and gastrointestinal (GI) problems news here: https://bit.ly/1ZGMEEZ…
Recent Posts
- Cosmetic laser therapy could be repurposed for localized scleroderma
- Antibody levels may help reflect quality of life in people with scleroderma
- Certain antibodies tied to poorer outcomes in systemic sclerosis
- Dexamethasone reduces inflammation, scarring in SSc mouse model: Study
- Survival improves for SSc-PAH patients on combination therapy
- Combination drug therapy boosts lung, skin health in SSc patients
- On choosing medicine’s side effects over scleroderma progression
- Telerehabilitation improves hand mobility in scleroderma women
- Molecular pathway ID’d as key driver of scarring in scleroderma
- Limited hand function disrupts daily life for people living with SSc